Carregant...

Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide

BACKGROUND: A cohort study was performed to identify ovarian reserve markers (ORM) that predicts amenorrhea or oligomenorrhea 6 months after cyclophosphamide CTX in women with breast cancer. METHODS: 52 eumenorrheic patients with breast cancer were enrolled. FSH, anti-Müllerian hormone (AMH), antral...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Ovarian Res
Autors principals: D’Avila, Ângela Marcon, Biolchi, Vanderlei, Capp, Edison, Corleta, Helena von Eye
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4678664/
https://ncbi.nlm.nih.gov/pubmed/26667243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-015-0209-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!